Muscle Relaxant Guidelines for Dialysis Patients

Anesthetic Use

For a dialysis patient requiring muscle relaxation during anesthesia, the American Society of Anesthesiologists recommends atracurium or cisatracurium due to their organ-independent elimination 1
Atracurium is the optimal choice because approximately half is eliminated by organ-independent Hofmann degradation and ester hydrolysis, with pharmacokinetics and pharmacodynamics remaining similar in patients with and without kidney failure 1, 3
Cisatracurium is equally appropriate and may be preferred as it is more potent than atracurium, resulting in lower doses and significantly less laudanosine metabolite generation 1, 3, 4
No dose modification is required for the initial dose in renal failure patients 1, 3, 7, 8, 5
The American Society of Anesthesiologists recommends avoiding rocuronium as it is mainly eliminated in urine and bile, with clearance significantly reduced in renal failure patients and wide variability in duration of action 1, 3, 4, 5
Succinylcholine should be absolutely avoided in dialysis patients, as it may cause treatment-resistant hyperkalemia, particularly in patients immobilized for ≥3 days 9

For non-anesthetic muscle spasm management, the American Geriatrics Society recommends baclofen as the safest choice, starting at 5 mg up to three times daily 2
Tizanidine is an alternative at 2 mg up to three times daily, though it requires close monitoring for orthostatic hypotension and sedation 2
The American Geriatrics Society lists muscle relaxants as potentially inappropriate medications for older adults due to anticholinergic effects, sedation, and increased fall risk 2, 10

Cyclobenzaprine should be avoided due to structural similarity to tricyclic antidepressants with comparable adverse effects including anticholinergic effects, CNS impairment, delirium, and increased fall risk 2, 10
Carisoprodol should be avoided entirely due to high risk of sedation, falls, and significant potential for physical and psychological dependence 2, 10
Orphenadrine should be avoided due to strong anticholinergic properties causing confusion, urinary retention, and cardiovascular instability 2
NSAIDs should not be used as they may impair renal function and are contraindicated in chronic renal failure 9

Never co-prescribe muscle relaxants with opioids or benzodiazepines, as this combination increases mortality risk 3- to 10-fold 2
Start with the lowest effective dose and shortest duration necessary 2
Monitor closely for orthostatic hypotension, sedation, and fall risk 2
If neuromuscular blockade reversal is needed after anesthesia, sugammadex can be administered at the usual dose despite renal failure 1, 3, 7, 8, 5
Always taper muscle relaxants after prolonged use to avoid withdrawal symptoms 10